GENE ONLINE|News &
Opinion
Blog

Autoimmune Disease
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Johnson & Johnson to Acquire Momenta Pharmaceutical Inc. for $6.5 Billion
2020-08-20
The Modern Authority in Genetics: Exclusive Interview with Dr. Yusuke Nakamura
2017-10-13
1 2
LATEST
Sanofi Secures FDA Fast Track Designation for its Chlamydia Prevention mRNA Vaccine
2025-03-27
Amaran Biotech Crowned “Best CDMO in Automated Aseptic Filling” at Taiwan Biopharma Excellence Awards 2025!
2025-03-26
GSK Launches First-of-Its-Kind Study on Shingles Vaccine and Dementia Risk in the UK
2025-03-26
23andMe Files for Bankruptcy, DNA Data of 15 Million Users at Risk
2025-03-25
Psychedelics Inching Forward – Psilocybin Therapy Shows Sustained Benefits for Treatment-Resistant Depression
2025-03-24
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top